1. Puerarin: a hepatoprotective drug from bench to bedside.
- Author
-
He, Yi-Xiang, Liu, Meng-Nan, Wu, Hao, Lan, Qi, Liu, Hao, Mazhar, Maryam, Xue, Jin-Yi, Zhou, Xin, Chen, Hui, and Li, Zhi
- Subjects
THERAPEUTIC use of isoflavones ,CHINESE medicine ,METABOLIC disorders ,AUTOPHAGY ,HERBAL medicine ,APOPTOSIS ,ALCOHOLIC liver diseases ,OXIDATIVE stress ,DRUG delivery systems ,LIVER diseases ,PHARMACY information services ,MEDICINAL plants ,INFLAMMATION ,BIOAVAILABILITY - Abstract
Pueraria is a time-honored food and medicinal plant, which is widely used in China. Puerarin, the main component extracted from pueraria, has a variety of pharmacological characteristics. In recent years, puerarin has received increasing attention for its significant hepatoprotective effects, such as metabolic dysfunction-associated steatotic liver disease, alcohol-related liver disease, and hepatic carcinoma. This paper explores the pharmacological effects of puerarin on various liver diseases through multiple mechanisms, including inflammation factors, oxidative stress, lipid metabolism, apoptosis, and autophagy. Due to its restricted solubility, pharmacokinetic studies revealed that puerarin has a low bioavailability. However, combining puerarin with novel drug delivery systems can improve its bioavailability. Meanwhile, puerarin has very low toxicity and high safety, providing a solid foundation for its further. In addition, this paper discusses puerarin's clinical trials, highlighting its unique advantages. Given its excellent pharmacological effects, puerarin is expected to be a potential drug for the treatment of various liver diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF